Marina S.D. Milan

Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC

Gonzalo Recondo, Magda Bahcall, Liam F. Spurr et al. · Clinical Cancer Research · 2020 · 210 citations

Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib

Ezra Y. Rosen, Melissa L. Johnson, Sarah Clifford et al. · Clinical Cancer Research · 2020 · 121 citations · Full text

Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA

Julianna Supplee, Marina S.D. Milan, Lee P. Lim et al. · Lung Cancer · 2019 · 81 citations · Full text

Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis

Yi Lee, Evan W. Clark, Marina S.D. Milan et al. · JCO Precision Oncology · 2020 · 28 citations · Full text

Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC

Michael L. Cheng, Christie J. Lau, Marina S.D. Milan et al. · JCO Precision Oncology · 2021 · 27 citations · Full text